| ID: | 87 | |
|---|---|---|
| Name: | Compound 87 | |
| Description: | Original numeration in publication: 31b | |
| Labels: | Test_set, Quinoxalines | |
| CAS: | ||
| InChi Code: | InChI=1S/C25H20N6O5S/c1-15-25(28-21-5-3-2-4-20(21)26-15)37-14-22(32)27-18-10-6-16(7-11-18)23(33)29-30-24(34)17-8-12-19(13-9-17)31(35)36/h2-13H,14H2,1H3,(H,27,32)(H,29,33)(H,30,34) |
pIC50: Negative logarithm of half-maximal inhibitory concentration [-log(uM)]
| Value | Source or prediction |
|---|---|
| 8.29 |
Alanazi, M. M.; Eissa, I. H.; Alsaif, N. A. a. O., A. J.; Alanazi, W. A.; Alasmari, A. F. a. A., H.; Elkady, H.; Elwan, A. Design, synthesis, docking, ADMET studies, and anticancer evaluation of new 3-methylquinoxaline derivatives as VEGFR-2 inhibitors and apoptosis inducers. J. Enzyme Inhib. Med. Chem. 2021, 36, 1760–1782. https://doi.org/10.1080/14756366.2021.1956488 |
| 7.6958 |
Eq1: VEGFR-2 inhibition (Data used to validate model) |